Osteoporosis is associated with antiepileptic drugs: A population-based study

Epileptic Disorders

Volumn 16, Issue 3, 2014, Pages 333-342

  Wu, Fang Jen ^a   Sheu, Shiow Yunn ^a   Lin, Herng Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiepileptic drug; Epilepsy; Osteoporosis

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ENZYME INDUCING ANTIEPILEPTIC DRUG; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NONENZYME INDUCING ANTIEPILEPTIC DRUG; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; TAIWAN; ADOLESCENT; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FACTUAL DATABASE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ANTIEPILEPTIC DRUG; EPILEPSY; OSTEOPOROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; TAIWAN; YOUNG ADULT;

EID: 84907543270     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2014.0673     Document Type: Article

References (34)

1. Arzimanoglou A, Ben-Menachem E, Cramer J, et al. The evolution of antiepileptic drug development and regulation. Epileptic Disord 2010;12:3-15.
2. Beerhorst K, Tan IY, De Krom M, et al. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy. Acta Neurol Scand 2013;128:273-80.
3. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004;3:618-21.
4. Beniczky SA, Viken J, Jensen LT, et al. Bone mineral density in adult patients treated with various antiepileptic drug. Seizure 2012;21:471-2.
5. Chen CC, Chen TF, Hwang YC, et al. Population-based survey on prevalence of adult patients with epilepsy in Taiwan (Keelung community-based integrated screening no. 12). Epilepsy Res 2006;72:67-74.
6. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-42.
7. Chung SD, Chen YK, Wu FJ, et al. Hormone therapy for prostate cancer and the risk of 11 stroke: a 5-year follow-up study. BJU Int 2012;109:1001-5.
8. Dent CE, Richens A, Rowe DJ, et al. Osteomalacia with longterm anticonvulsant therapy in epilepsy. Br Med J 1970;4:69-72.
9. Ensrud KE, Walczak TS, Blackwell T, et al. Antiepileptic drug use increases rates of bone lose in older women: a prospective study. Neurology 2004;62:2051-7.
10. Ensrud KE, Walczak TS, Blackwell TL, et al. Antiepileptic drug use and rates of hip bone loss in older men: A prospective study. Neurology 2008;71:723-30.
11. Fuller HR, Man NT, Lam Le T, et al. Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells. J Proteome Res 2010;9:4228-33.
12. Kang JH, Keller JJ, Lin HC. Bisphosphonates reduced the risk of acute myocardial 8 infarction: a 2-year follow-up study. Osteoporos Int 2013;24:271-7.
13. Khanna S, Pillai KK, Vohora D. Insights into liaison between antiepileptic drugs and bone. DrugDiscovToday 2009;14:428-35.
14. Kim SH, Lee JW, Choi KG, et al. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 2007;10:291-5.
15. Koo DL, Joo EY, Kim D, et al. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 2013;104:134-9.
16. Kruse R. Osteopathies in antiepileptic long-term therapy (preliminary report). Monatsschr Kinderheilkd 1968;116:378-81.
17. Kuan YC, Yen DJ, Yiu CH, et al. Treatment-seeking behavior of people with epilepsy in Taiwan: a preliminary study. Epilepsy Behav 2011;22:308-12.
18. Kulak CA, Borba VZ, Bilezikian JP, et al. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940-8.
19. Lado F, Spiegel R, Masur JH, et al. Value of routine screening for bone demineralizationinan urban population of patients with epilepsy. Epilepsy Res 2008;78:155-60.
20. Lee RH, Lyles KW, Sloane R, et al. The association of newer anticonvulsant medication and bone mineral density. Endocr Pract 2012;14:1-22.
21. Lin HC, Xirasagar S, Chen CH, et al. Physician's case volume of intensive care unit pneumonia admissions and in-hospital mortality. Am J Respir Crit Care Med 2008;177:989-94.
22. Mac TL, Tran DS, Quet F, et al. Epilepsy in Asia: epidemiology, aetiology and clinical management. Lancet Neurol 2007;6:533-43.
23. Martinez Perez JA, Palacios S, Garcia FC, et al. Assessing osteoporosis risk factors in Spanish menopausal women. Gynecol Endocrinol 2011;27:807-13.
24. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95.
25. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med 2004;71:S42-8.
26. Pack AM, Morrell M. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008;70:1586-93.
27. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol 2011;10:446-56.
28. Petty SJ, O'Brien TJ, Wark JD. Anti-epileptic medication and bone health. Osteoporos Int 2007;18:129-42.
29. Phabphal K, Limapichat K, Sathirapanya P, et al. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country. Epileptic Disord 2008;10:213-8. doi: 10.1684/epd.2008.0208.
30. Pugliatti M, Beghi E, Forsgren L, et al. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007;48:2224-33.
31. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increasedboneturnoverwithvalproatetherapyinadultswith epilepsy. Neurology 2001;57:445-9.
32. Shiek Ahmad B, Hill KD, O'Brien TJ, et al. Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology 2012;79:145-51.
33. Sheth RD, Binkley N, Hermann BP. Progressive bone deficit in epilepsy. Neurology 2008;70:170-6.
34. Suzuki Y, Nawata H, Soen S, et al. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab 2014;32:337-50.